Loading market intelligence…
Juniper Bio is a fictional biotechnology company used to demonstrate SVI's private-market intelligence tools. All financing, valuation and investor relationships on this profile are illustrative.
Juniper Bio is a fictional biotechnology company used to demonstrate SVI's private-market intelligence tools. All financing, valuation and investor relationships on this profile are illustrative.
Position by illustrative valuation within the tracked sector.
Explore sector ↗| 2026-04-07 | Series B | $54M | $6.2B | Cypress Capital | Marin Family Partners, Horizon Growth | Demo · Unverified |
| 2025-09-12 | Series A | $17M | Not disclosed | Cypress Capital | Marin Family Partners, Horizon Growth | Demo · Unverified |
| 2024-03-08 | Seed | $4M | Not disclosed | Cypress Capital | Marin Family Partners, Horizon Growth | Demo · Unverified |
Illustrative founding year
| Helix Discovery | Biotech | $36.1B | $483M | Growth |
| Cellular Atlas | Biotech | $16.3B | $204M | Series C+ |
| Cedar Bio | Biotech | $10.5B | $129M | Series C+ |
| Oak Bio | Biotech | $7.8B | $95M | Series B |
All metrics on this profile originate in the SVI illustrative dataset. Published and retrieved Sep 18, 2026. Last verified: not verified. No original external publication exists for synthetic records.
Demo dataset · Sep 18, 2026